KZR-261 in Subjects With Advanced Solid Malignancies

Active:	Yes
Cancer Type:	Colon/Rectal Cancer Eye Cancer Melanoma Prostate Cancer Solid Tumor Unknown Primary	NCT ID:	NCT05047536
Trial Phases:	Phase I	Protocol IDs:	KZR-261-101 (primary) NCI-2022-01096
Eligibility:	18 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	Kezar Life Sciences, Inc.
NCI Full Details:	http://clinicaltrials.gov/show/NCT05047536

Summary

A first-in-human, open-label, multicenter, Phase 1 study of KZR-261 designed to assess
the safety and tolerability, preliminary anti-tumor activity, and pharmacokinetics (PK)
of KZR-261, as well as identify the recommended Phase 2 dose (RP2D). The study comprises
a Part 1 (Dose Escalation) and a Part 2 (Dose Expansion) in solid organ tumors
(melanoma/uveal melanoma, mesothelioma, colorectal cancer, prostate cancer, and
"All-Tumors").

Objectives

The first-in-human, open-label, multicenter, Phase 1 study of KZR-261, Study KZR-261-101,
will be conducted in two parts (dose escalation and dose expansion) to evaluate the
safety and tolerability, pharmacokinetics, pharmacodynamics, and evaluate the preliminary
anti-tumor activity of KZR-261 in subjects with locally advanced or metastatic solid
malignancies for whom no therapeutics are available that can confer a reasonable
likelihood of clinical benefit. The 5 tumor cohorts in the dose expansion part include
advanced malignant:

- melanoma/uveal melanoma

- mesothelioma

- colorectal cancer

- castrate-resistant prostate cancer

- "All-Tumors"

Part 1 (Dose Escalation) and Part 2 (Dose Expansion) comprise a 4-week Screening Period,
a Treatment Period lasting approximately 24 weeks, 4-6-week Safety Follow-up, and a
12-month Long-Term Follow-up Period (after last dose of study treatment), for a total
study duration of approximately 20 months.

Treatment Sites in Georgia

Emory University Hospital - Midtown
550 Peachtree Street NE
Atlanta, GA 30308
404-686-4411
www.emoryhealthcare.org

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.